Repetitive Transcranial Magnetic Stimulation for Improving Cognitive Function in Patients With Mild Cognitive Impairment: A Systematic Review

Lijuan Jiang, HuiRu Cui, Caidi Zhang, Xinyi Cao, Nannan Gu, Yikang Zhu, Jijun Wang, Zhi Yang, Chunbo LiFrontiers in Aging Neuroscience 2021 · DOI

TL;DR

This systematic review and meta-analysis provides evidence that repetitive transcranial magnetic stimulation (rTMS) can significantly improve global cognitive function and memory in individuals with mild cognitive impairment (MCI). While generally safe with mild side effects, the quality of evidence for global cognitive function is low, highlighting the need for more high-quality studies.

What Problem Does This Paper Address?

Mild cognitive impairment (MCI) is a critical transitional stage between normal aging and dementia, often preceding Alzheimer's disease. Individuals with MCI experience noticeable cognitive decline but can still function independently. While pharmacological treatments for MCI have limited effectiveness, non-invasive brain stimulation techniques like rTMS have emerged as a promising alternative. However, a lack of robust, systematic evidence has made it difficult to definitively assess the efficacy and safety of rTMS for MCI. This paper aims to fill that gap by systematically reviewing and meta-analyzing existing research.

Methods

The researchers conducted a comprehensive literature search across nine electronic databases, identifying studies published in English and Chinese up to June 20, 2019. They screened these articles, extracted relevant data, and assessed the methodological quality of the included trials using the GRADE approach. A meta-analysis was performed using RevMan 5.3 software to pool the results from nine selected studies involving 369 participants. Subgroup analyses were conducted to explore the impact of stimulation site, frequency, and treatment duration.

Datasets

Not applicable. This paper is a systematic review and meta-analysis of existing studies, not a primary research study that collects or analyzes new datasets.

Key Insights and Ideas

  • rTMS shows promise for MCI: The core finding is that rTMS appears to be an effective intervention for improving cognitive function in individuals with MCI, particularly in global cognition and memory.
  • Targeting matters: Stimulation of the left hemisphere showed a significant enhancement in global cognitive function, while bilateral hemisphere stimulation was effective for both global cognition and memory. This suggests that the specific brain regions targeted by rTMS are crucial for its therapeutic effects.
  • Frequency and duration are key: High-frequency rTMS (≥5 Hz) was found to be more effective than low-frequency rTMS. Furthermore, a higher number of treatment sessions (≥20) was associated with better outcomes, indicating that sustained treatment is likely more beneficial.
  • Safety profile is favorable: While patients receiving rTMS experienced a higher rate of mild adverse effects (like headache and dizziness) compared to control groups, these effects were generally transient and not serious. Importantly, there was no significant difference in dropout rates, suggesting good patient acceptance.
  • Evidence quality is a concern: Despite the positive findings, the overall quality of evidence for the improvement in global cognitive function is rated as "low." This is primarily due to the heterogeneity of the studies and the relatively small number of trials included, especially for certain analyses.

Key Results

The meta-analysis revealed the following:

  • Global Cognitive Function: rTMS significantly improved global cognitive function (SMD 2.09, 95% CI 0.94 to 3.24, p = 0.0004). However, the quality of this evidence was rated as "low."
  • Memory: rTMS also significantly improved memory (SMD 0.44, 95% CI 0.16 to 0.72, p = 0.002), with "moderate-quality" evidence.
  • Executive Function and Attention: No significant improvement was observed in executive function and attention (p > 0.05).
  • Adverse Effects: Patients receiving rTMS had a higher incidence of mild adverse effects (RR 2.03, 95% CI 1.16 to 3.52, p = 0.01), with "moderate-quality" evidence.
  • Dropout Rate: There was no significant difference in dropout rates between the rTMS and control groups.

Limitations and Future Work

The authors acknowledge several limitations:

  • Small Sample Sizes: The included studies had relatively small sample sizes, which may limit the statistical power to detect effects and generalize findings.
  • Heterogeneity in Parameters: There was considerable variation in rTMS parameters (frequency, intensity, number of pulses) across studies, making it difficult to pinpoint optimal settings.
  • Language Bias: Most of the included trials were conducted in China, with only one from Brazil, potentially introducing language selection bias.
  • Risk of Bias: Some studies had limitations in random sequence generation, allocation concealment, and reporting of outcomes, contributing to the "low" quality of evidence for global cognitive function.

Future research should focus on:

  • High-Quality Randomized Controlled Trials: Conducting larger, well-designed RCTs with standardized protocols is crucial to improve the quality of evidence.
  • Optimal Parameter Identification: Further investigation is needed to determine the ideal stimulation parameters (site, frequency, intensity, duration) for maximizing therapeutic benefits.
  • Mechanism Exploration: Understanding the underlying mechanisms of rTMS's effects on cognition, potentially through neuroimaging and other biomarkers, is essential.
  • Subtyping MCI: Given the heterogeneity of MCI, future studies could benefit from stratifying participants based on MCI subtypes to tailor interventions more effectively.

Summary updated

Abstract

<b>Background:</b> Mild cognitive impairment (MCI) is an early stage of Alzheimer's disease. Repetitive transcranial magnetic stimulation (rTMS) has been widely employed in MCI research. However, there is no reliable systematic evidence regarding the effects of rTMS on MCI. The aim of this review was to evaluate the efficacy and safety of rTMS in the treatment of MCI. <b>Methods:</b> A comprehensive literature search of nine electronic databases was performed to identify articles published in English or Chinese before June 20, 2019. The identified articles were screened, data were extracted, and the methodological quality of the included trials was assessed. The meta-analysis was performed using the RevMan 5.3 software. We used the GRADE approach to rate the quality of the evidence. <b>Results:</b> Nine studies comprising 369 patients were included. The meta-analysis showed that rTMS may significantly improve global cognitive function (standardized mean difference [SMD] 2.09, 95% confidence interval [CI] 0.94 to 3.24, <i>p</i> = 0.0004, seven studies, <i>n</i> = 296; low-quality evidence) and memory (SMD 0.44, 95% CI 0.16 to 0.72, <i>p</i> = 0.002, six studies, <i>n</i> = 204; moderate-quality evidence). However, there was no significant improvement in executive function and attention (<i>p</i> > 0.05). Subgroup analyses revealed the following: (1) rTMS targeting the left hemisphere significantly enhanced global cognitive function, while rTMS targeting the bilateral hemispheres significantly enhanced global cognitive function and memory; (2) high-frequency rTMS significantly enhanced global cognitive function and memory; and (3) a high number of treatments ≥20 times could improve global cognitive function and memory. There was no significant difference in dropout rate (<i>p</i> > 0.05) between the rTMS and control groups. However, patients who received rTMS had a higher rate of mild adverse effects (risk ratio 2.03, 95% CI 1.16 to 3.52, <i>p</i> = 0.01, seven studies, <i>n</i> = 317; moderate-quality evidence). <b>Conclusions:</b> rTMS appears to improve global cognitive function and memory in patients with MCI and may have good acceptability and mild adverse effects. Nevertheless, these results should be interpreted cautiously due to the relatively small number of trials, particularly for low-frequency rTMS.
BibTeX
@inproceedings{jiang2021repetitive,
  author = {Lijuan Jiang and HuiRu Cui and Caidi Zhang and Xinyi Cao and Nannan Gu and Yikang Zhu and Jijun Wang and Zhi Yang and Chunbo Li},
  title = {{Repetitive Transcranial Magnetic Stimulation for Improving Cognitive Function in Patients With Mild Cognitive Impairment: A Systematic Review}},
  booktitle = {Frontiers in Aging Neuroscience},
  year = {2021},
  doi = {10.3389/fnagi.2020.593000},
}
Figure